C-reactive protein and brain natriuretic peptide as predictors of adverse events after lower extremity endovascular revascularization

Journal of Vascular Surgery

Volumn 60, Issue 3, 2014, Pages 652-660

  Stone, Patrick A ^a,c   Schlarb, Haley ^b   Campbell, John E ^a   Williams, David ^a   Thompson, Stephanie N ^b   John, Molly ^a   Campbell, James R ^a   Aburahma, Ali F ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b CHARLESTON AREA MEDICAL CENTER   (United States)

^c WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN;

ADULT; AGED; ANGIOGRAPHY; ANKLE BRACHIAL INDEX; ARTERIAL STENT; ARTERY RECONSTRUCTION; BARE METAL STENT; BYPASS SURGERY; CEREBROVASCULAR ACCIDENT; CLAUDICATION; CONFERENCE PAPER; CRITICAL LIMB ISCHEMIA; DEATH; DISEASE COURSE; DRUG ELUTING STENT; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; ILIAC ARTERY; LEG AMPUTATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMPUTATION; ANGIOPLASTY; ANKLE BRACHIAL INDEX; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIMB SALVAGE; LOWER EXTREMITY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STENTS; STROKE; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX; UP-REGULATION;

EID: 84908356208     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2014.03.254     Document Type: Conference Paper

References (24)

1. R. Ross Atherosclerosis - an inflammatory disease N Engl J Med 340 1999 115 126
2. P.M. Ridker, N. Rifai, L. Rose, J.E. Burning, and N.R. Cook Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 2002 1557 1565
3. P.M. Ridker Clinical application of C-reactive protein for cardiovascular disease detection and prevention Circulation 107 2003 363 369
4. C.M. Colley, A. Fleck, A.W. Goode, B.R. Muller, and M.A. Myers Early time course of acute phase protein response in man J Clin Pathol 36 1983 203 207
5. A. Shankar, J. Li, F.J. Nieto, B.E. Klein, and R. Klein Association between C-reactive protein level and peripheral artery disease among US adults without cardiovascular disease, diabetes, or hypertension Am Heart J 154 2007 495 501
6. M. Schillinger, M. Exner, W. Mlekusch, M. Haumer, H. Rumpold, and R. Ahmadi et al. Endovascular revascularization below the knee: 6-month results and predictive value of C-reactive protein level Radiology 227 2003 419 425
7. S. Bleda, J. De Haro, F. Acin, C. Varela, L. Esparza, and I.L. de Maturana Inflammatory burden predicts long-term outcomes in endovascular therapy in peripheral arterial disease Ann Vasc Surg 27 2013 459 466
8. H. Ishii, Y. Kumada, T. Toriyama, T. Aoyama, H. Takahashi, and T. Murohara Prognostic values of C-reactive protein levels on clinical outcome after endovascular therapy in hemodialysis patients with peripheral artery disease J Vasc Surg 52 2010 854 859
9. H. Ishii, T. Aoyama, H. Takahashi, D. Kamoi, M. Tanaka, and D. Yoshikawa et al. Serum albumin and C-reactive protein levels predict clinical outcome in hemodialysis patients undergoing endovascular therapy for peripheral artery disease Atherosclerosis 227 2013 130 134
10. K. Nakao, H. Itoh, Y. Saito, M. Mukoyama, and Y. Ogawa The natriuretic peptide family Curr Opin Nephrol Hypertens 5 1996 4 11
11. P. Svensson, U. de Faire, U. Niklasson, L.O. Hansson, and J. Östergren Plasma NT-proBNP concentration is related to ambulatory pulse pressure in peripheral artery disease 2005 Blood Press 99 106
12. T. Mueller, B. Dieplinger, W. Poelz, G. Endler, O.F. Wagner, and M. Haltmayer Amino-terminal pro-B-type natriuretic peptide as predictor of mortality in patients with symptomatic peripheral arterial disease: 5-year follow-up data from the Linz Peripheral Arterial Disease Study Clin Chem 55 2009 68 77
13. O. Schouten, S.E. Hoeks, D. Goei, J.J. Bax, H.J.M. Verhagen, and D. Poldermans Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery J Vasc Surg 49 2009 435 442
14. G. Bryce, C. Payne, S. Gibson, D. Byrne, C. Delles, and J. McClure et al. B-type natriuretic peptide predicts postoperative cardiac events and mortality after elective open abdominal aortic aneurysm repair J Vasc Surg 57 2013 345 353
15. D. Sacks, D.L. Marinelli, L.G. Martin, and J.B. Spies Reporting standards for clinical evaluation of new peripheral arterial revascularization devices J Vasc Interv Radiol 14 2003 S395 S400
16. S.E. Musicant, L.M. Taylor Jr., D. Peters, R.A. Schuff, R. Urankar, and G.J. Landry et al. Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease J Vasc Surg 43 2006 772 780
17. R.S. Vasan Biomarkers of cardiovascular disease: molecular basis and practical considerations Circulation 113 2006 2335 2362
18. A. Buffon, G.G. Liuzzo, L.M. Biasucci, P. Pasqualetti, V. Ramazzotti, and A.G. Rebuzzi et al. Elevated levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty J Am Coll Cardiol 34 1999 1512 1521
19. M. Schillinger, M. Haumer, A.G. Schlerka, W. Mlekusch, M. Exner, and R. Ahmadi et al. Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: the role of inflammation J Endovasc Ther 8 2001 477 483
20. T. Vainas, F.R.M. Stassen, R. de Graaf, E.L.L. Twiss, S.B. Herngreen, and R.J. Welten et al. C-reactive protein in peripheral arterial disease: relationship to severity of the disease and to future cardiovascular events J Vasc Surg 42 2005 243 251
21. C.D. Owens, P.M. Ridker, M. Belkin, A.D. Hamdan, F. Pomposelli, and F. Logerfo et al. Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery J Vasc Surg 45 2007 2 9
22. S. Rajagopalan, B.L. Croal, P. Bachoo, G.S. Hillis, B.H. Cuthbertson, and J. Brittenden N-terminal pro B-type natriuretic peptide is an independent predictor of postoperative myocardial injury in patients undergoing major vascular surgery J Vasc Surg 48 2008 912 917
23. S. Rajagopalan, B.L. Croal, J. Reeve, P. Bachoo, and J. Brittenden N-terminal pro-B-type natriuretic peptide is an independent predictor of all-cause mortality and MACE after major vascular surgery in medium-term follow-up Eur J Vasc Endovasc Surg 41 2011 657 662
24. P.M. Ridker, E. Danielson, F.A. Fonseca, J. Genest, A.M. Gotto Jr., and J.J. Kastelein et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207